Last reviewed · How we verify
NCT03415425
Optimizing the Influenza Clinical Decision Support Tool
NA trial testing Current Version of the Influenza Alert in Clinical Decision Support in 25,881 participants. Completed in 21 November 2023.
7 October 2023
Quick facts
| Lead sponsor | NYU Langone Health |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 25,881 |
| Start date | 16 January 2018 |
| Primary completion | 7 October 2023 |
| Estimated completion | 21 November 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Current Version of the Influenza Alert
- Alternate Modifications of the Influenza Alert
Conditions studied
- Clinical Decision Support — all drugs for Clinical Decision Support →
Sponsor
NYU Langone Health — full company profile →
Who can join
3 and older, any sex, with Clinical Decision Support. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The proposed study aims to examine several iterations of the Influenza Best Practice Alert at NYU Langone Health. The goal is to increase ordering of the influenza vaccine through the alert.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Applying A/B Testing to Clinical Decision Support: Rapid Randomized Controlled Trials.
Austrian J, Mendoza F, Szerencsy A, Fenelon L, et al · · 2021 · cited 31× · PMID 33835035 · DOI 10.2196/16651
Verify or expand the search:
- PubMed search for NCT03415425
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Clinical Decision Support
Currently open trials in the same condition.
- NCT06744543 — Clinical Decision Support to Identify Pediatric Patients With Undiagnosed Genetic Disease · NA · active not recruiting
- NCT03989167 — Clinical Decision Support for Familial Hypercholesterolemia · NA · recruiting
Other NYU Langone Health trials
Trials by the same sponsor.
- NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study · NA · not yet recruiting
- NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease · NA · not yet recruiting
- NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors · NA · not yet recruiting
- NCT06236087 — Overdose Prevention Centers and Behavioral Health · not yet recruiting
- NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03415425 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
- Last refreshed: 1 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03415425.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing